Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2020
  • 2021
  • FAQs
  • Articles
  • Search
  • Contact
  • 2020
  • 2021
  • FAQs
  • Articles
  • Latest Medicare News
  • Search


September 2020 Drug List Updates: Eighteen (18) new generic drugs added to many Medicare Part D plan formularies.

Category: Monthly Formulary Changes
Published on 2020-09-29 17:05:54


As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the September 2020 Medicare Part D formulary updates included 46 new drugs, 18 of which are new generic drugs - with a total of 33 new generic equivalents (variations of manufacturer, drug-strength, and packaging).

Below is a full list of the new generics added to the 2020 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:


Generic Drug Equivalent [Brand-Name Drug]

Number of
PDP
Formularies*

Number of
MAPD
Formularies*

CEFDINIR 250 MG/5 ML ORAL SUSPENSION [Omnicef]69391
DEFERASIROX 180 MG TABLET [Jadenu]51333
DEXABLISS 11 DAY 1.5 MG TABLET DS PK [ZCORT]19
DICLOFENAC EPOLAMINE 1.3% PATCH TD12 [Licart]2114
DVORAH 325-30-16 MG TABLET [Panlor]07
METHYLPHENIDATE ER 10 MG CAPSULE CSBP 40-60 [Ritalin LA]135
METHYLPHENIDATE ER 15 MG CAPSULE CSBP 40-60 [Aptensio XR]135
METHYLPHENIDATE ER 20 MG CAPSULE CSBP 40-60 [Ritalin LA]134
METHYLPHENIDATE ER 30 MG CAPSULE CSBP 40-60 [Ritalin LA]134
METHYLPHENIDATE ER 40 MG CAPSULE CSBP 40-60 [Ritalin LA]134
METHYLPHENIDATE ER 50 MG CAPSULE CSBP 40-60 [Metadate CD]135
METHYLPHENIDATE ER 60 MG CAPSULE CSBP 40-60 [Ritalin LA]135
METHYLPHENIDATE LA 20 MG CAPSULE CPBP 50-50 [Ritalin LA]9187
METHYLPHENIDATE LA 30 MG CAPSULE CPBP 50-50 [Ritalin LA]9186
MICAFUNGIN 100 MG VIAL [Mycamine]46303
MICAFUNGIN 50 MG VIAL [Mycamine]46301
NALOXONE 2 MG AUTO-INJECTOR[EVZIO]218
NITISINONE 10 MG CAPSULE [Orfadin]68368
NITISINONE 2 MG CAPSULE [Orfadin]68368
NITISINONE 5 MG CAPSULE [Orfadin]68368
NIZATIDINE 150 MG CAPSULE [Axid]47334
NIZATIDINE 300 MG CAPSULE [Axid]47335
POTASSIUM CL 20 MEQ-0.45% NACL IV SOLN63359
POTASSIUM CL 40 MEQ/100 ML SOL PIGGYBACK42286
RANOLAZINE ER 1,000 MG TABLET 12H [Ranexa]69390
RANOLAZINE ER 500 MG TABLET 12H [Ranexa]69390
TERIPARATIDE 620 MCG/2.48 ML PEN INJECTOR [Forteo]13165
VENLAFAXINE HCL 100 MG TABLET [Effexor]69393
VENLAFAXINE HCL 25 MG TABLET [Effexor]69393
VENLAFAXINE HCL 37.5 MG TABLET [Effexor]69393
VENLAFAXINE HCL 50 MG TABLET [Effexor]69393
VENLAFAXINE HCL 75 MG TABLET [Effexor]69393
VTOL LQ 50-325-40 MG/15 ML SOLUTION116
ZIPRASIDONE 20 MG/ML VIAL [Geodon]69387


*The number of formularies counts the unique formularies that offer this medication. As a note, the same formulary can be used by one or many different Medicare Part D plans. The same formulary can be used by both PDP and MAPD plans.

What Could the Addition of New Generic Drugs Mean to You?

  • You may be able to save money by switching from the brand-name drug to its generic equivalent – with your prescriber’s approval and a new prescription. Please note, you will need to look carefully at coverage costs as we have found that many 2020 generics are being offered on the same tier as their brand-name equivalent or the generics do not have a significantly lower retail price.

  • Your brand-name drug may no longer be available if a generic is now available. Based on past experience, you may find that many Medicare Part D plans discontinue coverage for the brand-name drug in the months following the introduction of the generic equivalent - or your plan may immediately drop the brand-name drug now that the generic is being introduced
    .
    If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug.

    You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.
As a note, both our Formulary Browser (you can view all the drugs covered by a single Medicare prescription drug plan) and our Q1Rx Drug Finder (you can view all the Medicare drug plans covering a single drug) have been updated with the September 2020 Medicare Part D formulary data.






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Ask a Pharmacist*
Have questions about your medication?

» Answers to Your Medication Questions, Free!
Available Monday - Friday
8am to 5pm MST
*A free service included with your no cost drug discount card.




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.